Phase III clinical trials with anamorelin HCl, a novel oral treatment for NSCLC cachexia.

Citation

• Abernethy, A. P., Temel, J. S., Currow, D., Gleich, L. L., & Friend, J. (2013). Phase III clinical trials with anamorelin HCl, a novel oral treatment for NSCLC cachexia.. Journal of Clinical Oncology, 31(15_suppl), tps9649. doi:10.1200/jco.2013.31.15_suppl.tps9649

Digital Object Identifier (doi)

• 10.1200/jco.2013.31.15_suppl.tps9649

Web Of Science Accession Number

Start Page

• tps9649

End Page

• tps9649

Volume

• 31

Issue

• 15_suppl

Place Of Publication

Abstract

UOW Authors

•   Currow, David

Publication Date

• 2013

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• Abernethy, A. P., Temel, J. S., Currow, D., Gleich, L. L., & Friend, J. (2013). Phase III clinical trials with anamorelin HCl, a novel oral treatment for NSCLC cachexia.. Journal of Clinical Oncology, 31(15_suppl), tps9649. doi:10.1200/jco.2013.31.15_suppl.tps9649

Digital Object Identifier (doi)

• 10.1200/jco.2013.31.15_suppl.tps9649

Web Of Science Accession Number

Start Page

• tps9649

End Page

• tps9649

Volume

• 31

Issue

• 15_suppl

Place Of Publication